1127 related articles for article (PubMed ID: 21937200)
141. Large-cell transformation of mycosis fungoides-differential diagnosis with implications for clinical management: a consensus statement of the US Cutaneous Lymphoma Consortium.
Kadin ME; Hughey LC; Wood GS
J Am Acad Dermatol; 2014 Feb; 70(2):374-6. PubMed ID: 24438952
[No Abstract] [Full Text] [Related]
142. Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients.
Vincenzi B; Zoccoli A; Schiavon G; Iuliani M; Pantano F; Dell'aquila E; Ratta R; Muda AO; Perrone G; Brunelli C; Correale P; Riva E; Russo A; Loupakis F; Falcone A; Santini D; Tonini G
Eur J Cancer; 2013 Apr; 49(6):1501-8. PubMed ID: 23266047
[TBL] [Abstract][Full Text] [Related]
143. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis.
Stoll JR; Willner J; Oh Y; Pulitzer M; Moskowitz A; Horwitz S; Myskowski P; Noor SJ
J Am Acad Dermatol; 2021 Nov; 85(5):1073-1090. PubMed ID: 33940098
[TBL] [Abstract][Full Text] [Related]
144. Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates.
Saleh JS; Subtil A; Hristov AC
Hum Pathol; 2023 Oct; 140():75-100. PubMed ID: 37802757
[TBL] [Abstract][Full Text] [Related]
145. [Cutaneous lymphomas].
Ingen-Housz-Oro S; Bagot M
Rev Prat; 2009 Nov; 59(9):1207-15. PubMed ID: 19961071
[TBL] [Abstract][Full Text] [Related]
146. In search of prognostic indicators for lymphomatoid papulosis: a retrospective study of 123 patients.
de Souza A; el-Azhary RA; Camilleri MJ; Wada DA; Appert DL; Gibson LE
J Am Acad Dermatol; 2012 Jun; 66(6):928-37. PubMed ID: 21982062
[TBL] [Abstract][Full Text] [Related]
147. Immunophenotypic studies in cutaneous T-cell lymphomas: clinical implications.
Ralfkiaer E; Wollf-Sneedorff A; Thomsen K; Vejlsgaard GL
Br J Dermatol; 1993 Dec; 129(6):655-9. PubMed ID: 8286247
[TBL] [Abstract][Full Text] [Related]
148. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.
Laharanne E; Oumouhou N; Bonnet F; Carlotti M; Gentil C; Chevret E; Jouary T; Longy M; Vergier B; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2010 Jun; 130(6):1707-18. PubMed ID: 20130593
[TBL] [Abstract][Full Text] [Related]
149. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
[TBL] [Abstract][Full Text] [Related]
150. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.
Brown DN; Wieser I; Wang C; Dabaja BS; Duvic M
J Am Acad Dermatol; 2015 Dec; 73(6):976-86. PubMed ID: 26476898
[TBL] [Abstract][Full Text] [Related]
151. Mapping Toll-like receptor activity in different stages of cutaneous T-cell lymphoma.
Kado JA; Shango M; Mehregan C; Mehregan DR
Am J Dermatopathol; 2012 Oct; 34(7):691-8. PubMed ID: 22407070
[TBL] [Abstract][Full Text] [Related]
152. Current status of histone deacetylase inhibitors in cutaneous T-cell lymphoma.
Trager MH; Geskin LJ
G Ital Dermatol Venereol; 2019 Dec; 154(6):681-695. PubMed ID: 31859467
[TBL] [Abstract][Full Text] [Related]
153. Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2011 Nov; 86(11):928-48. PubMed ID: 21990092
[TBL] [Abstract][Full Text] [Related]
154. Associated Hematolymphoid Malignancies in Patients With Lymphomatoid Papulosis: A Canadian Retrospective Study.
AbuHilal M; Walsh S; Shear N
J Cutan Med Surg; 2017; 21(6):507-512. PubMed ID: 28614957
[TBL] [Abstract][Full Text] [Related]
155. The role of hematopoietic stem-cell transplantation in cutaneous T-cell lymphoma.
Hoff NP; Bruch-Gerharz D
G Ital Dermatol Venereol; 2010 Jun; 145(3):345-59. PubMed ID: 20461043
[TBL] [Abstract][Full Text] [Related]
156. Expression of miR-155 and miR-126 in situ in cutaneous T-cell lymphoma.
Kopp KL; Ralfkiaer U; Nielsen BS; Gniadecki R; Woetmann A; Ødum N; Ralfkiaer E
APMIS; 2013 Nov; 121(11):1020-4. PubMed ID: 24033365
[TBL] [Abstract][Full Text] [Related]
157. Cutaneous pseudo-T-cell lymphomas. A clinicopathologic study of 20 patients.
Rijlaarsdam JU; Scheffer E; Meijer CJ; Willemze R
Cancer; 1992 Feb; 69(3):717-24. PubMed ID: 1730122
[TBL] [Abstract][Full Text] [Related]
158. Recent Advances in Cutaneous T-cell Lymphoma: Diagnostic and Prognostic Considerations.
Cocks M; Porcu P; Wick MR; Gru AA
Surg Pathol Clin; 2019 Sep; 12(3):783-803. PubMed ID: 31352988
[TBL] [Abstract][Full Text] [Related]
159. Expression of follicular helper T-cell markers in primary cutaneous T-cell lymphoma.
Park JH; Han JH; Kang HY; Lee ES; Kim YC
Am J Dermatopathol; 2014 Jun; 36(6):465-70. PubMed ID: 24162385
[TBL] [Abstract][Full Text] [Related]
160. Primary cutaneous lymphomas: a population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003.
Riou-Gotta MO; Fournier E; Mermet I; Pelletier F; Humbert P; Danzon A; Aubin F
Leuk Lymphoma; 2008 Aug; 49(8):1537-44. PubMed ID: 18766967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]